These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11340029)

  • 21. Warfarin versus aspirin in paroxysmal atrial fibrillation.
    Cheng TO
    J Am Coll Cardiol; 1998 Jun; 31(7):1702. PubMed ID: 9626858
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevalence of inappropriate use of digoxin in 136 patients on digoxin and prevalence of use of warfarin or aspirin in 89 patients with persistent or paroxysmal atrial fibrillation.
    Lleva P; Aronow WS; Gutwein AH
    Am J Ther; 2009; 16(6):e41-3. PubMed ID: 19940604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial fibrillation and stroke prevention.
    Lip GY; Lim HS
    Lancet Neurol; 2007 Nov; 6(11):981-93. PubMed ID: 17945152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review: anticoagulants may be better than antiplatelet agents for nonfatal stroke but not other vascular or fatal events in nonrheumatic AF.
    Ebrahim S; Taylor F
    ACP J Club; 2001; 135(2):A17. PubMed ID: 11571899
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of stroke in patients with atrial fibrillation.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
    [No Abstract]   [Full Text] [Related]  

  • 26. Better stroke prevention.
    Ornato JP
    Health News; 2001 Apr; 7(4):1-2. PubMed ID: 11303474
    [No Abstract]   [Full Text] [Related]  

  • 27. Chronic atrial fibrillation: optimizing anticoagulation.
    Wheeldon NM
    QJM; 1997 Oct; 90(10):609-11. PubMed ID: 9415341
    [No Abstract]   [Full Text] [Related]  

  • 28. Warfarin, aspirin, or both after myocardial infarction.
    Aronow WS
    N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12530434
    [No Abstract]   [Full Text] [Related]  

  • 29. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual or triple therapy in patients with atrial fibrillation and drug-eluting stents?
    Sambola A; García-Dorado D
    Coron Artery Dis; 2015 Aug; 26(5):367-8. PubMed ID: 25955251
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 32. Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation.
    Kutner M; Nixon G; Silverstone F
    Arch Intern Med; 1991 Oct; 151(10):1950-3. PubMed ID: 1929682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of coumadin and aspirin in atrial fibrillation.
    Hutter AM
    Trans Am Clin Climatol Assoc; 1996; 107():79-85; discussion 85-6. PubMed ID: 8725562
    [No Abstract]   [Full Text] [Related]  

  • 34. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 35. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer].
    Mooe T
    Lakartidningen; 2008 Sep 10-16; 105(37):2472-3. PubMed ID: 19006861
    [No Abstract]   [Full Text] [Related]  

  • 36. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
    Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH
    Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Choosing between warfarin (Coumadin) and aspirin therapy for patients with atrial fibrillation.
    Ebell MH
    Am Fam Physician; 2005 Jun; 71(12):2348-50. PubMed ID: 15999873
    [No Abstract]   [Full Text] [Related]  

  • 38. Long term anticoagulation or antiplatelet treatment. Inclusion criteria determine results of review.
    Mant J; Fitzmaurice D; Murray E; Lip GY; Hobbs FD
    BMJ; 2001 Jul; 323(7306):233-4; author reply 235-6. PubMed ID: 11496884
    [No Abstract]   [Full Text] [Related]  

  • 39. Who is ineligible for warfarin in atrial fibrillation?
    Verheugt FW
    Lancet; 2009 Aug; 374(9689):510-1. PubMed ID: 19683630
    [No Abstract]   [Full Text] [Related]  

  • 40. Vitamin E and blood thinners. You advised readers not to take extra vitamin E if they were taking aspirin or Coumadin. Why?
    Johns Hopkins Med Lett Health After 50; 1999 Oct; 11(8):8. PubMed ID: 10614194
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.